SCHEMBL1308775

SCHEMBL1308775

O=CC=Cc1ccc(C=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.65
KDM4E B2RXH2 2/20 0.65
MAPT P10636 1/20 0.65
TRPA1 O75762 1/20 0.64
LMNA P02545 1/20 0.64
ALOX5 P09917 1/20 0.64
MAPK1 P28482 1/20 0.64
XDH P47989 2/20 0.52
CYP2A6 P11509 4/20 0.48
HSD17B10 Q99714 1/20 0.48
ALDH5A1 P51649 1/20 0.48
ABAT P80404 1/20 0.48
CCNB2 O95067 1/20 0.45
CDK1 P06493 1/20 0.45
CDK4 P11802 1/20 0.45
CCNB1 P14635 1/20 0.45
CCND1 P24385 1/20 0.45
CCNB3 Q8WWL7 1/20 0.45
TYR P14679 1/20 0.42
CYP2A13 Q16696 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1308773 1.00 ALDH1A1 (0.65) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL1310214 0.91 ALDH1A1 (0.75) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL1310216 0.91 ALDH1A1 (0.75) ALDH1A1KDM4EMAPTTRPA1LMNA
Cinnamaldehyde SCHEMBL10628048 0.87 ALDH1A1 (0.86) ALDH1A1KDM4EMAPTTRPA1LMNA
Cinnamaldehyde SCHEMBL10631921 0.87 ALDH1A1 (0.86) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL5552912 0.86 APP (0.55) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL18921374 0.83 FBP1 (0.49) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL18921375 0.83 FBP1 (0.49) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL4195177 0.82 CYP2A6 (0.58) ALDH1A1KDM4ECYP2A6HSD17B10ALDH5A1
SCHEMBL9004502 0.82 CYP2A6 (0.58) ALDH1A1KDM4ECYP2A6HSD17B10ALDH5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8053577-B2 Derivatives of 5,9-methanocycloocta[b]pyridin-2-(1H)-one, their preparation and use as analgesics ZHANG HESHENG 2011-11-08 US disclosed
US-20090118320-A1 DERIVATIVES OF 5,9-METHANOCYCLOOCTA[B]PYRIDIN-2-(1H)-ONE, THEIR PREPARATION AND USE AS ANALGESICS ZHANG HESHENG 2009-05-07 US disclosed
EP-2044937-A1 ANALGESIC 5, 9 - METHANOCYCLOOCTA (b) PYRIDIN - 2 (1H) - ONE DERIVATIVES, THEIR PREPARATION METHOD AND USE Tianjin Hemey Bio-Tech Co., Ltd. (CN) 2009-04-08 EP disclosed
EP-1458679-A2 PYRROLIDINE DERIVATIVES AS PROSTAGLANDIN MODULATORS Applied Research Systems ARS Holding N.V. (AN) 2004-09-22 EP disclosed
WO-2003053923-A2 PYRROLIDINE DERIVATIVES AS PROSTAGLANDIN MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2003-07-03 WO disclosed
EP-0912567-A1 CARBOLINE DERIVATIVES ICOS CORPORATION (US) 1999-05-06 EP disclosed
WO-1997043287-A1 CARBOLINE DERIVATIVES ICOS CORPORATION (US) 1997-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118320-A1 DERIVATIVES OF 5,9-METHANOCYCLOOCTA[B]PYRIDIN-2-(1H)-ONE, THEIR PREPARATION AND USE AS ANALGESICS CHRNA9, NR3C2, CBR3 ALDH1A1 1806/4885KDM4E 3356/4885MAPT 3559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.